Nico Wulffraat

1996–2024 年に発表

128
論文数
21,168
被引用数
85
h 指数
123
i10 指数

被引用数

Nico Wulffraat の年別被引用数1983 年: 被引用 1 件1996 年: 被引用 1 件1997 年: 被引用 1 件1998 年: 被引用 1 件2000 年: 被引用 26 件2001 年: 被引用 26 件2002 年: 被引用 45 件2003 年: 被引用 61 件2004 年: 被引用 56 件2005 年: 被引用 76 件2006 年: 被引用 76 件2007 年: 被引用 100 件2008 年: 被引用 74 件2009 年: 被引用 105 件2010 年: 被引用 116 件2011 年: 被引用 150 件2012 年: 被引用 137 件2013 年: 被引用 139 件2014 年: 被引用 173 件2015 年: 被引用 150 件2016 年: 被引用 166 件2017 年: 被引用 156 件2018 年: 被引用 197 件2019 年: 被引用 697 件2020 年: 被引用 721 件2021 年: 被引用 862 件2022 年: 被引用 528 件2023 年: 被引用 299 件2024 年: 被引用 556 件2025 年: 被引用 147 件2026 年: 被引用 1 件1984〜1995 年は被引用が無いため表示していません1999 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 1,383 件、この内訳の 16%イギリス: 引用元論文 731 件、この内訳の 8.5%イタリア: 引用元論文 677 件、この内訳の 7.8%ドイツ: 引用元論文 623 件、この内訳の 7.2%オランダ: 引用元論文 488 件、この内訳の 5.7%フランス: 引用元論文 436 件、この内訳の 5.1%カナダ: 引用元論文 373 件、この内訳の 4.3%中国: 引用元論文 278 件、この内訳の 3.2%スペイン: 引用元論文 243 件、この内訳の 2.8%日本: 引用元論文 235 件、この内訳の 2.7%スイス: 引用元論文 218 件、この内訳の 2.5%トルコ: 引用元論文 182 件、この内訳の 2.1%
0%16%その他 32.1%

分野

  • Medicine69.9%
  • Biochemistry, Genetics and Molecular Biology17.7%
  • Immunology and Microbiology9.1%
  • Neuroscience1.2%
  • Health Professions0.7%
  • Social Sciences0.5%
  • その他0.9%

トピック

  • Autoimmune and Inflammatory Disorders Research11.8%
  • Rheumatoid Arthritis Research and Therapies5%
  • Immune Cell Function and Interaction3.5%
  • Inflammasome and immune disorders3.3%
  • Adolescent and Pediatric Healthcare3.1%
  • Systemic Lupus Erythematosus Research2.9%
  • その他70.4%

共著者

全論文

検索で開く
  1. 2019 update of EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases

    著者: , , , , , , , , , , , , , , , , , , , , - Annals of the Rheumatic Diseases 2019 被引用: 812

  2. 2016 Classification Criteria for Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis: A European League Against Rheumatism/American College of Rheumatology/Paediatric Rheumatology International Trials Organisation Collaborative Initiative

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Nico Wulffraat, Erkan Demirkaya, Hermine I. Brunner, Alberto Martini, Nicolino Ruperto, Randy Q. Cron - Arthritis & Rheumatology 2015 被引用: 771

  3. Toward New Classification Criteria for Juvenile Idiopathic Arthritis: First Steps, Pediatric Rheumatology International Trials Organization International Consensus

    著者: , , , , , , , , , , , , , , - The Journal of Rheumatology 2018 被引用: 546

  4. Randomized Trial of Tocilizumab in Systemic Juvenile Idiopathic Arthritis

    著者: , , , , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2012 被引用: 873

  5. 2016 Classification Criteria for Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Nico Wulffraat, Erkan Demirkaya, Hermine I. Brunner, Alberto Martini, Nicolino Ruperto, Randy Q. Cron - Annals of the Rheumatic Diseases 2016 被引用: 397

  6. European consensus-based recommendations for diagnosis and treatment of immunoglobulin A vasculitis—the SHARE initiative

    著者: , , , , , , , , , , , , , , , , , , , - Lara D. Veeken 2019 被引用: 315

  7. Two Randomized Trials of Canakinumab in Systemic Juvenile Idiopathic Arthritis

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Flávio Sztajnbok, K. Lheritier, Kenneth Abrams, Dennis Kim, Alberto Martini, Daniel J. Lovell - New England Journal of Medicine 2012 被引用: 709

  8. Phenotypic variability and disparities in treatment and outcomes of childhood arthritis throughout the world: an observational cohort study

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Yahya Aghighi, Maya-Feriel Aiche, Constantin Ailioaie, Nuray Aktay Ayaz, Safiya Al‐Abrawi, Е.I. Alexeeva, Jordi Antón, Adriana Apostol, O Arguedas, Tadej Avčin, Patrizia Barone, Lillemor Berntson, Alina Boteanu, Yaryna Boyko, Rubén Burgos‐Vargas, Inmaculada Calvo Penadés, Gaëlle Chédeville, Rolando Cimaz, Adele Civino, Rita Consolini, Tamás Constantin, Rubén Cuttica, Tomas Dallos, Neil A. Martin, Silvia Magni‐Manzoni, Carmen De Cunto, Pavla Doležalová, Maria Ekelund, Yasser El Miedany, Graciela Espada, Anne Estmann Christensen, Ivan Foeldvari, Romina Gallizzi, Gerd Ganser, V. Gerloni, Johannes‐Peter Haas, Liora Harel, Miroslav Harjaček, Soad Hashad, Troels Herlin, Cristina Herrera, Michaël Hofer, Dirk Holzinger, Gerd Horneff, Hans-Iko Huppertz, N Iagăru, Amparo Ibanez Estrella, Maka Ioseliani, Rik Joos, Sheila Knupp Feitosa de Oliveira, Sylvia Kamphuis, Özgür Kasapçopur, María Martha Katsicas, Raju Khubchandani, Anuela Kondi, Liisa Kröger, Francesco La Torre, Matilda Láday, Pekka Lahdenne, Maria Cristina Maggio, Maria Greca Magnolia, Clara Malagón, Merja Malin, Silvana Martino, José Melo‐Gomes, Pablo Mesa-del-Castillo, Andrea Militaru, Kirsten Minden, Angela Miniaci, Mohammad Hasan Moradinejad ほか 40 名 - The Lancet Child & Adolescent Health 2019 被引用: 214

  9. Treating juvenile idiopathic arthritis to target: recommendations of an international task force

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Josef S Smolen - Annals of the Rheumatic Diseases 2018 被引用: 357

  10. Haematopoietic stem cell transplantation for autoimmune diseases

    著者: , , , , , , - Nature Reviews Rheumatology 2017 被引用: 181

  11. Mutations in RAB27A cause Griscelli syndrome associated with haemophagocytic syndrome

    著者: , , , , , , , , , , - Nature Genetics 2000 被引用: 952

  12. Evolution, trends, outcomes, and economics of hematopoietic stem cell transplantation in severe autoimmune diseases

    著者: , , , , , , , , , , , , , , , , , , - Blood Advances 2017 被引用: 216

  13. Consensus-based recommendations for the management of uveitis associated with juvenile idiopathic arthritis: the SHARE initiative

    著者: , , , , , , , , , , , , , , , , , , , , , , - Annals of the Rheumatic Diseases 2018 被引用: 207

  14. Canakinumab in patients with systemic juvenile idiopathic arthritis and active systemic features: results from the 5-year long-term extension of the phase III pivotal trials

    著者: , , , , , , , , , , , , , , , , , , , , , , , , - Annals of the Rheumatic Diseases 2018 被引用: 110

  15. Prednisone versus prednisone plus ciclosporin versus prednisone plus methotrexate in new-onset juvenile dermatomyositis: a randomised trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Maria Trachana, Antonella Meini, Emma Allain‐Launay, Clarissa Pilkington, Veronika Vargová, Carine Wouters, Simona Angioloni, Alberto Martini - The Lancet 2015 被引用: 232

  16. European evidence-based recommendations for diagnosis and treatment of childhood-onset systemic lupus erythematosus: the SHARE initiative

    著者: , , , , , , , , , , , , , , , , , , , - Annals of the Rheumatic Diseases 2017 被引用: 206

  17. European evidence-based recommendations for the diagnosis and treatment of childhood-onset lupus nephritis: the SHARE initiative

    著者: , , , , , , , , , , , , , , , , , , , - Annals of the Rheumatic Diseases 2017 被引用: 160

  18. Treatment to Target Using Recombinant Interleukin‐1 Receptor Antagonist as First‐Line Monotherapy in New‐Onset Systemic Juvenile Idiopathic Arthritis: Results From a Five‐Year Follow‐Up Study

    著者: , , , , , , , , , , , , , , - Arthritis & Rheumatology 2019 被引用: 186

  19. Secondary autoimmune diseases occurring after HSCT for an autoimmune disease: a retrospective study of the EBMT Autoimmune Disease Working Party

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Éliane Gluckman, Dominique Farge, on behalf of the EBMT Autoimmune Disease Working Party - Blood 2011 被引用: 169

  20. Presence of ATM protein and residual kinase activity correlates with the phenotype in ataxia-telangiectasia: A genotype-phenotype study

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Malcolm A. M. R. Taylor, Marcel van Deuren, Michèl A.A.P. Willemsen - Human Mutation 2011 被引用: 172

  21. The PRINTO criteria for clinically inactive disease in juvenile dermatomyositis

    著者: , , , , , , , , , , , , , , , , , , , , , - Annals of the Rheumatic Diseases 2012 被引用: 164

  22. Autologous stem cell transplantation aids autoimmune patients by functional renewal and TCR diversification of regulatory T cells

    著者: , , , , , , , , , , , , , - Blood 2015 被引用: 106

  23. Recommendations for the management of autoinflammatory diseases

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , - Annals of the Rheumatic Diseases 2015 被引用: 276

  24. Effectiveness of First‐Line Treatment With Recombinant Interleukin‐1 Receptor Antagonist in Steroid‐Naive Patients With New‐Onset Systemic Juvenile Idiopathic Arthritis: Results of a Prospective Cohort Study

    著者: , , , , , , - Arthritis & Rheumatology 2013 被引用: 263